Strength training + health, evidence-forward
RSS feed · 7 articles
Public health guidelines recommend lifting twice a week, but the study behind that number found three days worked better. Jordan Feigenbaum argues lifting doesn't hurt the heart, carries lower injury risk than running, and shows no real ceiling for strength, bone density, or metabolic benefits, so most people should train roughly double the current guideline.
In 1985 a panel of obstetricians banned pregnant women from raising their heart rate past 140 beats per minute, a number invented by consensus, not data (00:01). The same pattern, rules built on vibes rather than evidence, shaped a century of bans on heavy lifting for women, children, and anyone squatting below parallel, until later studies quietly reversed nearly all of them.
Exercise still protects health during wildfire smoke, and lifting is safer than cardio because it barely raises breathing rate. Training right at failure isn't required for muscle growth either, since easier sets and even indirect fractional sets still add measurable stimulus, so individual response matters more than hitting an exact rep-in-reserve number.
No: men above roughly 20% body fat can build muscle in a modest calorie deficit by spending stored fat as fuel. Sports scientist Eric Helms says below about 12% body fat the reverse happens, so a small surplus helps; in between, calorie balance barely matters if training and protein are dialed in.
Obesity is not simply a muscle shortage: lean mass on a DEXA scan predicts no falls, fractures, or death in 18,800 older adults (21:44). Barbell Medicine host Dr. Jordan Feigenbaum argues the real damage comes from where fat lands, what molecular form it takes, and how fast it moves, drawing on GLUT4 transporter mechanics and GLP-1 trial data.
The personal fat threshold theory says obesity begins when a person's fat cells run out of storage room, not at any fixed weight or BMI. Once storage fills up, fatty acids leak into the liver, muscle, and pancreas, causing insulin resistance. Removing fat surgically does not reverse this; restoring storage capacity does.
Barbell Medicine physicians Jordan Feigenbaum and Austin Baraki say testosterone therapy in the US is both overprescribed and underprescribed. They point to a 45-man Sydney trial where raising testosterone from 310 to 510 ng/dL did not beat placebo, and to the Traverse trial's reassuring two-year heart-safety data.
